Special Lecture: Novel Cellular Factors Inhibiting HIV and Other Viral Infections

Speaker: Shan-Lu Liu, MD, Ph.D.
演讲人:刘善虑 博士
When: February 28, 2015 (Saturday), from 7:00 pm
时间:2015 年2 月28 日(星期六)晚上七时起
Where: Health Science Building, Room K-450
地点:华盛顿大学医学院K-450 会议室
Note: Free parking during seminar time in UW campus

About speaker: Dr. Shan-Lu Liu is currently an associate professor in the Department of Molecular Microbiology and Immunology, and an investigator of Bond Life Sciences Center, University of Missouri. He is also an adjunct professor of the Department of Microbiology and Immunology, McGill University. He received his medical training in China and his Ph.D. degree from the Department of Pathology at the University of Washington in 2003. He was named as Canada Research Chair in Virology and Gene Therapy at McGill University during 2005-2010. His current research is focused on membrane fusion and cellular entry of enveloped RNA viruses, as well as innate immunity to viral infections. The model viruses that his lab has been studying include HIV, influenza A virus, HCV, and Ebola virus. He will speak on two novel families of cellular factors, i.e., IFITMs (IFN-induced transmembrane proteins) and TIMs (T-cell immunoglobulin and mucin domain proteins), which broadly inhibit viral infections.

Best Regards,
SCBA office

October 2014

Dear SCBA Members and Friends:

As promised, our highly anticipated SCBA All-Member Meeting will take place on November 1st, Saturday, from 1:30pm to 6:00pm, at the UW Genome Sciences Building (Foege-060).

This year, we have lined up world class speakers from local academic and non-profit institutions, as well as biotech industry. The keynote speaker will be Dr. William A. Catterall, Professor and Chair of the Department of Pharmacology at University of Washington, and a member of the US National Academy of Science and the Royal Society of London, UK. Dr. Catterall will speak on structural and functional studies of the voltage-gated sodium channels. In addition, we will have “2014 Gateway Cancer Researcher of the Year” Dr. Edward H. Lin from UW/FHCRC to share with us his award winning ADAPT trial for advanced colorectal cancer (CRC); Dr. Yiwu He, Associate Director of Translational Sciences from Bill and Melinda Gates Foundation, to discuss vision and strategy for fighting global infectious diseases including Ebola; and Dr. Che-Leung Law, a Senior Director of Seattle Genetics, to talk about industrial perspective of drug development.

During the meeting, we will also elect new members to join the SCBA Board.

We highly encourage you all to come join us for this exciting event, discussing cutting-edge sciences, sharing the significant accomplishments of our members, and socializing.

The registration fee is $15, which covers the annual membership and a dinner.

Please RSVP to office@scbahome.org so that we can prepare logistics accordingly.

If you have any further questions, feel free to contact Dr. Ning Zheng (nzheng@u.washington.edu) and/or Dr. Qiang Tian (Qiang.Tian@systemsbiology.org).

We look forward to seeing you all on Nov. 1st.

Best regards,

SCBA Board

May 2014

Dear members,

The Seattle Chinese Biomedical Association (SCBA) Board is delighted to announce three upcoming events that will take place in the rest of 2014. On June 7th, we will host a panel discussion about career development in industry, featuring four active members from local pharma/biotech companies. On August 9th, our annual summer BBQ picnic will be held at the Matthew Beach, where new and old members can get together, relax, and socialize. On Novemer 1st, we will celebrate
our organization’s 20th anniversary with the long-due annual full member meeting, highlighted by a prominent keynote speaker, a review of our activities, and election of the new President,Secretary-General, and Board members.

Please mark your calendar and look out for announcement of the details of these exciting activities. We are looking forward to seeing you on all three events.

Sincerely yours,

ZHENG Ning, PhD, President
TIAN Qiang, MD PhD, Secretary-General

On behalf of the SCBA Board